Skip to main content

Advertisement

SpringerLink
Log in

Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Ferritin is known to be involved in numerous physiological roles, such as iron storage, as well as various pathological conditions and in generalized inflammatory states. Hyperferritinemia is also encountered in the setting of hemophagocytic lymphohistiocytosis (HLH). Current diagnostic criteria exist to define HLH based on several clinical and biochemical markers, including the serum ferritin level. In this study, we retrospectively evaluated the value of ferritin >500 ng/mL in diagnosing HLH in 344 consecutive patients admitted to the medical intensive care unit at our hospital. Nine cases of HLH were identified. Comparison of the HLH with the non-HLH group showed that their maximum median serum ferritin level was 25,652 (range 1977–100,727 ng/mL) versus 1180 (503–85,168 ng/mL) (P < 0.001), platelets were 30 (5–92 × 103/μL) versus 113 (0–507 × 103/μL) (P < 0.001), absolute neutrophil counts were 2.56 (0.02–23.7 × 103/μL) versus 7.7 (0.01–82.7 × 103/μL) (P = 0.002), and triglycerides were 255 (156–394 mg/dL) versus 127 (17–624 mg/dL) (P = 0.002), respectively. Using a receiver operating characteristic curve, the optimal maximum serum ferritin level for the diagnosis of HLH was 3951 ng/mL, exceeding the current diagnostic cutoff set forth in the HLH-2004 guidelines. These data suggest that a higher cutoff value of ferritin level may have improved utility in the diagnosis of secondary HLH in the critical care setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematol Am Soc Hematol Educ Progr. 2009;2009(1):127–31.

    Article  Google Scholar 

  2. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000;6(6):601–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Farquhar JW, Claireaux AE. Familial haemophagocytic reticulosis. Arch Dis Child. 1952;27(136):519–25.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Arico M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia. 1996;10(2):197–203.

    CAS  PubMed  Google Scholar 

  5. Gholam C, Grigoriadou S, Gilmour KC, Gaspar HB. Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management. Clin Exp Immunol. 2011;163(3):271–83.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Zhang K, Chandrakasan S, Chapman H, Valencia CA, Husami A, Kissell D, et al. Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. Blood. 2014;124(8):1331–4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Niece JA, Rogers ZR, Ahmad N, Langevin AM, McClain KL. Hemophagocytic lymphohistiocytosis in Texas: observations on ethnicity and race. Pediatr Blood Cancer. 2010;54(3):424–8.

    Article  PubMed  Google Scholar 

  8. Ishii E, Ohga S, Tanimura M, Imashuku S, Sako M, Mizutani S, et al. Clinical and epidemiologic studies of familial hemophagocytic lymphohistiocytosis in Japan. Japan LCH Study Group. Med Pediatr Oncol. 1998;30(5):276–83.

    Article  CAS  PubMed  Google Scholar 

  9. Dandoy C, Grimley M. Secondary hemophagocytic lymphohistiocytosis (HLH) from a presumed brown recluse spider bite. J Clin Immunol. 2014;34(5):544–7.

    Article  PubMed  Google Scholar 

  10. Dinleyici EC, Bor O, Kiremitci A, Aksit MA. Secondary hemophagocytic lymphohistiocytosis associated with meningococcemia. Pediatr Hematol Oncol. 2006;23(8):683–6.

    Article  PubMed  Google Scholar 

  11. Pandey R, Kochar R, Kemp S, Rotaru D, Shah SV. Ehrlichiosis presenting with toxic shock-like syndrome and secondary hemophagocytic lymphohistiocytosis. J Ark Med Soc. 2013;109(13):280–2.

    PubMed  Google Scholar 

  12. Kleynberg RL, Schiller GJ. Secondary hemophagocytic lymphohistiocytosis in adults: an update on diagnosis and therapy. Clin Adv Hematol Oncol. 2012;10(11):726–32.

    PubMed  Google Scholar 

  13. Imashuku S, Hibi S, Sako M, Ishii T, Kohdera U, Kitazawa K, et al. Heterogeneity of immune markers in hemophagocytic lymphohistiocytosis: comparative study of 9 familial and 14 familial inheritance-unproved cases. J Pediatr Hematol Oncol. 1998;20(3):207–14.

    Article  CAS  PubMed  Google Scholar 

  14. Schneider EM, Lorenz I, Muller-Rosenberger M, Steinbach G, Kron M, Janka-Schaub GE. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood. 2002;100(8):2891–8.

    Article  CAS  PubMed  Google Scholar 

  15. Rosado FG, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol. 2013;139(6):713–27.

    Article  CAS  PubMed  Google Scholar 

  16. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.

    Article  PubMed  Google Scholar 

  17. Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2004;124(1):4–14.

    Article  PubMed  Google Scholar 

  18. Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;50(6):1227–35.

    Article  PubMed  Google Scholar 

  19. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–54.

    Article  CAS  PubMed  Google Scholar 

  20. Hentze MW. Translational regulation of ferritin biosynthesis by iron: a review. Curr Stud Hematol Blood Transfus. 1991;58:115–26.

    Article  CAS  PubMed  Google Scholar 

  21. Kwak EL, Larochelle DA, Beaumont C, Torti SV, Torti FM. Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem. 1995;270(25):15285–93.

    Article  CAS  PubMed  Google Scholar 

  22. Porto G, De Sousa M. Iron overload and immunity. World J Gastroenterol. 2007;13(35):4707–15.

    CAS  PubMed  Google Scholar 

  23. Ward RJ, Crichton RR, Taylor DL, Della Corte L, Srai SK, Dexter DT. Iron and the immune system. J Neural Transm. 2011;118(3):315–28.

    Article  CAS  PubMed  Google Scholar 

  24. Nemeth E, Ganz T. Anemia of inflammation. Hematol Oncol Clin North Am. 2014;28(4):671–81.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Zandman-Goddard G, Shoenfeld Y. Hyperferritinemia in autoimmunity. Isr Med Assoc J. 2008;10(1):83–4.

    PubMed  Google Scholar 

  26. Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev. 2009;23(3):95–104.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Maiwall R, Kumar S, Chaudhary AK, Maras J, Wani Z, Kumar C, et al. Serum ferritin predicts early mortality in patients with decompensated cirrhosis. J Hepatol. 2014;61(1):43–50.

    Article  CAS  PubMed  Google Scholar 

  28. Agmon-Levin N, Rosario C, Katz BS, Zandman-Goddard G, Meroni P, Cervera R, et al. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS). Lupus. 2013;22(13):1327–35.

    Article  CAS  PubMed  Google Scholar 

  29. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002;99(10):3505–16.

    Article  CAS  PubMed  Google Scholar 

  30. Switala JR, Hendricks M, Davidson A. Serum ferritin is a cost-effective laboratory marker for hemophagocytic lymphohistiocytosis in the developing world. J Pediatr Hematol Oncol. 2012;34(3):e89–92.

    Article  CAS  PubMed  Google Scholar 

  31. Li F, Li P, Zhang R, Yang G, Ji D, Huang X, et al. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China. Med Oncol. 2014;31(4):902.

    Article  CAS  PubMed  Google Scholar 

  32. Li J, Wang Q, Zheng W, Ma J, Zhang W, Wang W, et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore). 2014;93(2):100–5.

    Article  CAS  Google Scholar 

  33. Walsh TS, Saleh EE. Anaemia during critical illness. Br J Anaesth. 2006;97(3):278–91.

    Article  CAS  PubMed  Google Scholar 

  34. Maung AA, Kaplan LJ. Role of fibrinogen in massive injury. Minerva Anestesiol. 2014;80(1):89–95.

    CAS  PubMed  Google Scholar 

  35. Leung JM, Sin DD. Biomarkers in airway diseases. Can Respir J. 2013;20(3):180–2.

    PubMed Central  PubMed  Google Scholar 

  36. Riviere S, Galicier L, Coppo P, Marzac C, Aumont C, Lambotte O, et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med. 2014;127(11):1118–25.

    Article  PubMed  Google Scholar 

  37. Rajajee S, Ashok I, Manwani N, Rajkumar J, Gowrishankar K, Subbiah E. Profile of hemophagocytic lymphohistiocytosis; efficacy of intravenous immunoglobulin therapy. Indian J Pediatr. 2014;81(12):1337–41.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None to disclose.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Kentucky, Lexington, KY, USA

    Hayder Saeed, Ryan R. Woods, Joshua Lester, Roger Herzig, Zartash Gul & Gregory Monohan

  2. Department of Hematology and Blood and Marrow Transplant, Markey Cancer Center, University of Kentucky, 800 Rose Street, CC 402, Lexington, KY, 40536, USA

    Hayder Saeed, Roger Herzig, Zartash Gul & Gregory Monohan

Authors
  1. Hayder Saeed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryan R. Woods
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joshua Lester
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roger Herzig
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zartash Gul
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gregory Monohan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hayder Saeed.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saeed, H., Woods, R.R., Lester, J. et al. Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting. Int J Hematol 102, 195–199 (2015). https://doi.org/10.1007/s12185-015-1813-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-015-1813-1

Keywords

Search

Navigation